Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: The MASTER trial

Journal of the American College of Cardiology

Volumn 60, Issue 19, 2012, Pages 1975-1984

  Stone, Gregg W ^a,b   Abizaid, Alexandre ^c   Silber, Sigmund ^d   Dizon, Jose M ^a,b   Merkely, Béla ^e   Costa, Ricardo A ^c   Kornowski, Ran ^f   Abizaid, Andrea ^c   Wojdya, Roman ^g   Maehara, Akiko ^a,b   Dressler, Ovidiu ^b   Brener, Sorin J ^b,h   Bar, Eli ⁱ   Dudek, Dariusz ^j  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d Heart Center   (Germany)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f RABIN MEDICAL CENTER   (Israel)

^g Krakow Center of Invasive Cardiology Electrotherapy and Angiology   (Poland)

^h NEW YORK METHODIST HOSPITAL   (United States)

ⁱ InspireMD   (Israel)

^j UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

more..

Author keywords

embolic protection; myocardial infarction; reperfusion

Indexed keywords

MGUARD; UNCLASSIFIED DRUG; METAL; POLYETHYLENE TEREPHTHALATE;

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYETHYLENE TEREPHTHALATE MICRONET MESH COVERED STENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; STENT THROMBOSIS; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY THROMBOSIS; DEVICES; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PROSTHESIS; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POLYETHYLENE TEREPHTHALATES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 84868204030     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.004     Document Type: Article

References (36)

1. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. E.G. Nabel, E. Braunwald A tale of coronary artery disease and myocardial infarction N Engl J Med 366 2012 54 63
3. M.J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, H. De Raedt, C.J. Vrints Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
4. M. Kondo, A. Nakano, D. Saito, Y. Shimono Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction J Am Coll Cardiol 32 1998 898 903
5. A. Maes, F. Van de Werf, J. Nuyts, G. Bormans, W. Desmet, L. Mortelmans Impaired myocardial tissue perfusion early after successful thrombolysis Impact on myocardial flow, metabolism, and function at late follow-up Circulation 92 1995 2072 2078
6. R. Erbel, G. Heusch Coronary microembolization - its role in acute coronary syndromes and interventions Herz 24 1999 558 575
7. R.S. Schwartz, A. Burke, A. Farb Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology J Am Coll Cardiol 54 2009 2167 2173
8. J.P. Henriques, F. Zijlstra, J.P. Ottervanger Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112 1117
9. T. Svilaas, P.J. Vlaar, I.C. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567
10. Y. Inaba, J.A. Chen, N. Mehta, S.R. Bergmann Impact of single or multicentre study design on the results of trials examining the efficacy of adjunctive devices to prevent distal embolisation during acute myocardial infarction Eurointervention 5 2009 375 383
11. H. Thiele, J. Wöhrle, R. Hambrecht Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: the randomised Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial Lancet 379 2012 923 931
12. G.W. Stone, A. Maehara, B. Witzenbichler Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
13. A. Schomig, G. Ndrepepa, J. Mehilli A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction J Am Coll Cardiol 44 2004 2073 2079
14. C.L. Grines, D.A. Cox, G.W. Stone Coronary angioplasty with or without stent implantation for acute myocardial infarction N Engl J Med 341 1999 1949 1956
15. G.W. Stone, C.L. Grines, D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
16. C.O. Costantini, G.W. Stone, R. Mehran Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J Am Coll Cardiol 44 2004 305 312
17. E. Kaluski, S. Tsai, M. Klapholz Coronary stenting with MGuard: from conception to human trials Cardiovasc Revasc Med 9 2008 88 94
18. A.K. Jain, M.T. Rothman Thrombus entrapment by a novel mesh-covered stent in ST-segment elevation myocardial infarction J Am Coll Cardiol 58 2011 e39
19. E. Kaluski, K.E. Hauptmann, R. Muller, S. Tsai, M. Klapholz, E. Grube Coronary stenting with MGuard: first-in-man trial J Invasive Cardiol 20 2008 511 515
20. F. Maia, J.R. Costa Jr., A. Abizaid Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization Catheter Cardiovasc Interv 76 2010 86 92
21. D. Dudek, A. Dziewierz, L. Rzeszutko Mesh covered stent in ST-segment elevation myocardial infarction EuroIntervention 6 2010 582 589
22. F. Piscione, G. Battista, S. Cassese Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: Safety, feasibility, and impact on myocardial reperfusion Catheter Cardiovasc Interv 75 2010 715 721
23. S.J. Brener, E. Cristea, R. Mehran Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the Harmonizing Outcomes with Revascularization and Stents in AMI (HORIZONS-AMI) trial Am Heart J 162 2011 1044 1051
24. M.B. McEntegart, A.J. Kirtane, E. Cristea Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 59 2012 1745 1751
25. G.W. Stone, D. Cox, E. Garcia Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction Circulation 104 2001 636 641
26. M.G. McLaughlin, G.W. Stone, E. Aymong Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial J Am Coll Cardiol 44 2004 1215 1223
27. C.E. Buller, Y. Fu, K.W. Mahaffey ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation 118 2008 1335 1346
28. R.J. Kim, E.L. Chen, J.A. Lima, R.M. Judd Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 1996 3318 3326
29. C.J. Choi, S. Haji-Momenian, J.M. Dimaria Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction J Cardiovasc Magn Reson 6 2004 917 925
30. V. Schrächinger, C.W. Hamm, T. Münzel A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts J Am Coll Cardiol 42 2003 1360 1369
31. G. Stankovic, A. Colombo, P. Presbitero Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial Circulation 108 2003 37 42
32. M.A. Turco, M. Buchbinder, J.J. Popma Pivotal, randomized U.S. study of the Symbiot covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial Catheter Cardiovasc Interv 68 2006 379 388
33. G.W. Stone, S. Goldberg, C. O'Shaughnessy 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts J Am Coll Cardiol Intv 4 2011 300 309
34. G.W. Stone, H. Parise, B. Witzenbichler Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial J Am Coll Cardiol 56 2010 1597 1604
35. G.W. Stone, B. Witzenbichler, G. Guagliumi Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
36. G. De Luca, M.T. Dirksen, C. Spaulding Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621